What should you know about TNF inhibitors and rheumatoid arthritis?

Tumour necrosis factor, or TNF, is one messenger involved in inflammation. TNF inhibitors block this messenger to help control rheumatoid arthritis activity. When inflammation is active, people may experience joint pain, joint swelling, joint stiffness, morning joint stiffness, hand swelling, or finger stiffness. Reducing inflammation may protect function, but the response differs between individuals and the medicine does not remove the condition.

Treatment may be given by injection or infusion, depending on the medicine. A clinician will consider previous treatments, other illnesses, infection history, pregnancy plans, and vaccination needs before choosing a suitable option.

Complete the recommended checks before starting, which may include a review for infections and vaccination status. Follow the prescribed schedule and store or administer injections exactly as instructed. Keep a record of doses, symptoms, and infections, and attend follow-up visits so disease activity and tolerability can be reviewed.

Do not double a missed dose or combine immune-modifying treatments without medical guidance. Ask before receiving a vaccine, starting a new medicine, or travelling with the treatment. Continue any agreed exercise or joint-protection plan.

Tell your healthcare team promptly about fever, a persistent cough, painful urination, unusual skin sores, or other signs of infection. Seek urgent help for severe breathing difficulty, facial swelling, fainting, or a rapidly worsening allergic reaction after a dose. Report new neurological symptoms, vision changes, or a major change in joint symptoms rather than waiting for a routine review.

Ask which TNF inhibitor is being considered, how it is given, what checks are needed first, and how soon a response will be assessed. Clarify missed-dose instructions, vaccine advice, infection precautions, travel storage, pregnancy considerations, and what to do before surgery or dental treatment.